Status:
COMPLETED
Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients
Lead Sponsor:
IrisZorg
Collaborating Sponsors:
Fonds Psychische Gezondheid
Dutch EMDR Association
Conditions:
Alcohol Dependence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
One interesting approach to the treatment of addiction is the use of Eye Movement Desensitization and Reprocessing (EMDR) (Shapiro, 1989). Although research on the feasibility and efficacy of EMDR on ...
Eligibility Criteria
Inclusion
- A primary diagnosis of alcohol dependence or abuse (meeting the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV-TR criteria (American Psychiatric Association, 2000);
- Age of at least 18 years or older;
- Can speak and read Dutch language;
- Consent (written) to postponed information given.
Exclusion
- Meeting the DSM-IV-TR (American Psychiatric Association, 2000) criteria for current (in the past 2 weeks) addiction and regular use (at least once per week in the last two weeks before baseline screening) of drugs other than alcohol or nicotine (relative exclusion: decision on case-by-case basis whether it leads to therapy-interference);
- Meeting the DSM-IV (American Psychiatric Association, 2000) criteria for current (in the last two weeks before baseline screening) regular alcohol use (at least \> 21E (women) or \> 28E (men) per week) (relative exclusion: decision on case-by-case basis) (relative exclusion: decision on case-by-case basis whether it leads to therapy-interference);
- Meeting the DSM-IV (American Psychiatric Association, 2000) criteria for current post-traumatic stress disorder (PTSD);
- Severe, current (since the start of regular treatment) psychiatric symptoms (especially manic, psychotic, suicidal and aggressive symptoms) that may endanger participants or others and jeopardize study adherence.
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2016
Estimated Enrollment :
109 Patients enrolled
Trial Details
Trial ID
NCT01828866
Start Date
September 1 2013
End Date
August 1 2016
Last Update
September 15 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IrisZorg
Arnhem, Gelderland, Netherlands, 6800 AJ